Austrian Wearable Cardioverter Defibrillator Registry

• Conditions: Heart Failure; Sudden Death; Sudden Cardiac Arrest; Ventricular Dysfunction; Ventricular Tachycardia; Ventricular Fibrillation

• Registration Number: NCT02816047
• Lead Sponsor: Medical University of Graz

Brief Summary

Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI \<40days, recent PCI/CABG \< 3months etc.).

Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.

Detailed Description

Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients

Study Timeline

• Study Start: 2014-11
• Study First Submitted: 2016-05-17
• Study First Submitted QC: 2016-06-23
• Study First Posted: 2016-06-28
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-13
• Last Update Posted: 2021-09-14
• Primary Completion: 2021-12
• Study Completion: 2022-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 450

Inclusion Criteria

• patients, with a prescribed WCD according to guidelines in an austrian center

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants treated with WCD-treated ventricular arrhythmias	during WCD wearing period; average of 1 year	Number of participants treated with WCD-treated ventricular arrhythmias

Trial Locations

Locations (1)

Medical University of Graz/ Division of Cardiology; 🇦🇹 Graz, Austria